Investment Stage

Focus Areas

About Investor

Claire Leurent is Managing Director at AbbVie Ventures, the corporate venture arm of AbbVie, where she leads strategic life sciences investing from the Cambridge, Massachusetts area. As a venture investor she focuses on biotech and pharmaceutical opportunities, including therapeutics and healthcare platforms, and typically invests from seed through later private rounds with validated check sizes in the $100K to $5.0M range from her prior role as Principal, Venture Investments at Johnson & Johnson Innovation – JJDC. Her sector lens spans biotech, health economics, connected health and digital health, and she has experience deploying capital across stages from seed to IPO, PIPE and SPAC transactions. Previously she was Principal at JJDC, bio sector investment director at Samsung Ventures and a project manager at FORENAP Pharma. She holds a PhD in molecular and cellular biology from the University of Strasbourg and an MBA from MIT Sloan School of Management.